G C Finkel - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Clinical Chemistry|November 1, 1993

Clinical applications of serum and tissue markers in malignant disease: breast cancer as the paradigmG F Schwartz, R Schwarting, P Rabindranauth, et al.

Cancer|November 15, 1992

Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance aloneG F Schwartz, G C Finkel, J C Garcia, et al.

Gynecologic Oncology|April 11, 1992

Primary vaginal adenocarcinoma of the intestinal type associated with adenosisH Yaghsezian, J P Palazzo, G C Finkel, et al.

Neurosurgery|January 1, 1989

Distribution of 10B after infusion of Na210B12H11SH into a patient with malignant astrocytoma: implications for boron neutron capture therapyG C Finkel, C E Poletti, R G Fairchild, et al.

Human Pathology|March 1, 1997

Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressivaF H Gannon, F S Kaplan, E Olmsted, et al.

Radiology|July 1, 1994

Stability of malignant breast microcalcificationsA S Lev-Toaff, S A Feig, V L Saitas, et al.

Cancer|March 15, 1994

Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequentialG F Schwartz, D L Carter, E F Conant, et al.

Ultrasonics|June 1, 2000

Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: initial resultsM H Chaudhari, F Forsberg, A Voodarla, et al.

International Journal of Cancer|September 27, 1996

Synthesis of a nickel tetracarboranylphenylporphyrin for boron neutron-capture therapy: biodistribution and toxicity in tumor-bearing miceM Miura, P L Micca, C D Fisher, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990

Uptake of a nido-carboranylporphyrin by human glioma xenografts in athymic nude mice and by syngeneic ovarian carcinomas in immunocompetent miceS B Kahl, D D Joel, M M Nawrocky, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Clinical Chemistry|November 1, 1993

Clinical applications of serum and tissue markers in malignant disease: breast cancer as the paradigmG F Schwartz, R Schwarting, P Rabindranauth, et al.

Cancer|November 15, 1992

Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance aloneG F Schwartz, G C Finkel, J C Garcia, et al.

Gynecologic Oncology|April 11, 1992

Primary vaginal adenocarcinoma of the intestinal type associated with adenosisH Yaghsezian, J P Palazzo, G C Finkel, et al.

Neurosurgery|January 1, 1989

Distribution of 10B after infusion of Na210B12H11SH into a patient with malignant astrocytoma: implications for boron neutron capture therapyG C Finkel, C E Poletti, R G Fairchild, et al.

Human Pathology|March 1, 1997

Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressivaF H Gannon, F S Kaplan, E Olmsted, et al.

Radiology|July 1, 1994

Stability of malignant breast microcalcificationsA S Lev-Toaff, S A Feig, V L Saitas, et al.

Cancer|March 15, 1994

Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequentialG F Schwartz, D L Carter, E F Conant, et al.

Ultrasonics|June 1, 2000

Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: initial resultsM H Chaudhari, F Forsberg, A Voodarla, et al.

International Journal of Cancer|September 27, 1996

Synthesis of a nickel tetracarboranylphenylporphyrin for boron neutron-capture therapy: biodistribution and toxicity in tumor-bearing miceM Miura, P L Micca, C D Fisher, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990

Uptake of a nido-carboranylporphyrin by human glioma xenografts in athymic nude mice and by syngeneic ovarian carcinomas in immunocompetent miceS B Kahl, D D Joel, M M Nawrocky, et al.

Pageof 1